CSBR logo

CSBR

Champions Oncology Inc.

$6.77
+$0.11(+1.65%)
34
Overall
50
Value
18
Tech
--
Quality
Market Cap
$95.14M
Volume
13.54K
52W Range
$4.07 - $11.99
Target Price
$12.00

Company Overview

Mkt Cap$95.14MPrice$6.77
Volume13.54KChange+1.65%
P/E Ratio20.2Open$6.63
Revenue$56.9MPrev Close$6.66
Net Income$4.7M52W Range$4.07 - $11.99
Div YieldN/ATarget$12.00
Overall34Value50
Quality--Technical18

No chart data available

About Champions Oncology Inc.

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

ABCD
1SymbolPriceChangeVol
2CSBR$6.77+1.7%13.54K
3
4
5
6

Get Champions Oncology Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.